Suvi Sorsa
PhD, Chief Operating Officer
Suvi Sorsa is the Chief Operating Officer of TILT Biotherapeutics Oy, where she is responsible for the company’s day-to-day operations and oversees all development and cross-functional activities to advance its oncolytic virus pipeline.
Having been with the company for over a decade, she has played a central role in developing TILT’s platform, advancing it from preclinical research and regulatory engagement to clinical trial execution through Phase I studies. An effective team leader, she combines deep scientific expertise in cancer biology and gene therapy with hands-on experience in building and operating a clinical-stage biotech company.
She holds a PhD from the University of Helsinki and previously worked at Ark Therapeutics.
